Amy Wong - Aug 23, 2023 Form 4 Insider Report for Apexigen, Inc. (APGN)

Role
SVP, Finance and Operations
Signature
/s/ Francis Sarena, by power of attorney
Stock symbol
APGN
Transactions as of
Aug 23, 2023
Transactions value $
-$5,993
Form type
4
Date filed
8/25/2023, 07:20 PM
Previous filing
Jun 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APGN Common Stock Tax liability -$5.99K -15.6K -18.95% $0.39 66.6K Aug 23, 2023 Direct F1
transaction APGN Common Stock Disposed to Issuer -66.6K -100% 0 Aug 23, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APGN Employee Stock Option (right to buy) Disposed to Issuer -22.3K -100% 0 Aug 23, 2023 Common Stock 22.3K $1.27 Direct F3
transaction APGN Employee Stock Option (right to buy) Disposed to Issuer -8.71K -100% 0 Aug 23, 2023 Common Stock 8.71K $1.47 Direct F4
transaction APGN Employee Stock Option (right to buy) Disposed to Issuer -231K -100% 0 Aug 23, 2023 Common Stock 231K $1.66 Direct F5
transaction APGN Employee Stock Option (right to buy) Disposed to Issuer -15.4K -100% 0 Aug 23, 2023 Common Stock 15.4K $2.25 Direct F6
transaction APGN Employee Stock Option (right to buy) Disposed to Issuer -13.8K -100% 0 Aug 23, 2023 Common Stock 13.8K $2.25 Direct F7
transaction APGN Employee Stock Option (right to buy) Disposed to Issuer -71.2K -100% 0 Aug 23, 2023 Common Stock 71.2K $3.62 Direct F8
transaction APGN Employee Stock Option (right to buy) Disposed to Issuer -28.7K -100% 0 Aug 23, 2023 Common Stock 28.7K $4.59 Direct F9
transaction APGN Employee Stock Option (right to buy) Disposed to Issuer -25.6K -100% 0 Aug 23, 2023 Common Stock 25.6K $4.59 Direct F10
transaction APGN Employee Stock Option (right to buy) Disposed to Issuer -15.4K -100% 0 Aug 23, 2023 Common Stock 15.4K $4.59 Direct F11
transaction APGN Employee Stock Option (right to buy) Disposed to Issuer -76.8K -100% 0 Aug 23, 2023 Common Stock 76.8K $2.46 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Amy Wong is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units.
F2 Pursuant to an Agreement and Plan of Merger, dated as of May 23, 2023 (the "Merger Agreement"), by and among the Issuer, Pyxis Oncology, Inc. ("Pyxis"), and Ascent Merger Sub Corp., at the effective time of the merger (the "Effective Time"), each share of Issuer common stock was exchanged for 0.1725 shares of Pyxis common stock and rounded down to the nearest whole share.
F3 The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 3,852 shares of Pyxis common stock at an exercise price of $7.37 per share.
F4 The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 1,502 shares of Pyxis common stock at an exercise price of $8.53 per share.
F5 The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 39,761 shares of Pyxis common stock at an exercise price of $9.63 per share.
F6 The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 2,650 shares of Pyxis common stock at an exercise price of $13.05 per share.
F7 The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 2,385 shares of Pyxis common stock at an exercise price of $13.05 per share.
F8 The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 12,274 shares of Pyxis common stock at an exercise price of $20.99 per share.
F9 The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 4,947 shares of Pyxis common stock at an exercise price of $26.61 per share.
F10 The shares subject to the option vest in 48 equal monthly installments beginning on February 1, 2020. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 4,417 shares of Pyxis common stock at an exercise price of $26.61 per share.
F11 The shares subject to the option vest in 48 equal monthly installments beginning on February 1, 2021. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 2,649 shares of Pyxis common stock at an exercise price of $26.61 per share.
F12 The shares subject to the option vest in 48 equal monthly installments beginning on February 1, 2022. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 13,248 shares of Pyxis common stock at an exercise price of $14.27 per share.